Immunoglobulin A anti‐phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual by Frodlund, M., Vikerfors, A., Grosso, G., Skogh, T., Wetterö, J., Elvin, K., Gunnarsson, I., Kastbom, A., Dahlström, Ö., Rönnelid, J., Svenungsson, E., Sjöwall, C.

Get full text

Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays by Vikerfors, Anna, Johansson, Anna-Britta, Gustafsson, Johanna T, Jönsen, Andreas, Leonard, Dag, Zickert, Agneta, Nordmark, Gunnel, Sturfelt, Gunnar, Bengtsson, Anders, Rönnblom, Lars, Gunnarsson, Iva, Elvin, Kerstin, Svenungsson, Elisabet

Get full text

Immunoglobulin A anti-phospholipid antibodies in Swedish cases with systemic lupus erythematosus: associations with disease phenotypes, vascular events, and damage accrual by Frodlund, M., Vikerfors, A., Elvin, K., Rönnelid, Johan, Svenungsson, E., Sjowall, C.

Get full text

Studies of microparticles in patients with the antiphospholipid syndrome (APS) by Vikerfors, A, Mobarrez, F, Bremme, K, Holmström, M, Ågren, A, Eelde, A, Bruzelius, M, Antovic, A, Wallén, H, Svenungsson, E

Get full text

C0467: Increased Levels of Thrombin Activatable Fibrinolysis Inhibitor – TAFI Correlate with Complement Activation in Patients with the Antiphospholipid Syndrome by Antovic, A, Vikerfors, A, Woodhams, B, Adam, M, Svenungsson, E

Get full text

The Expression Of Microparticles In The Blood Of Patients With Systemic Lupus Erythematosus (SLE): Phenotypic Characterization And Clinical Associations by Mobarrez, F., Vikerfors, A., Gustafsson, J., Gunnarsson, I., Zickert, A., Larsson, Anders, Pisetsky, D., Wallen, H., Svenungsson, E.

Get full text

P.39 Decreased fibrin clot porosity in patients with antiphospholipid syndrome by Vikerfors, A, Svenungsson, E, Bremme, K, Holmström, M, Antovic, A

Get full text

Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations by Mobarrez, Fariborz, Vikerfors, Anna, Gustafsson, Johanna T., Gunnarsson, Iva, Zickert, Agneta, Larsson, Anders, Pisetsky, David S., Wallén, Håkan, Svenungsson, Elisabet

Get full text

Thrombin activatable fibrinolysis inhibitor (TAFI) — A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS) by Grosso, Giorgia, Vikerfors, Anna, Woodhams, Barry, Adam, Mariette, Bremme, Katarina, Holmström, Margareta, Ågren, Anna, Eelde, Anna, Bruzelius, Maria, Svenungsson, Elisabet, Antovic, Aleksandra

Get full text

Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome by Vikerfors, Anna, Svenungsson, Elisabet, Ågren, Anna, Mobarrez, Fariborz, Bremme, Katarina, Holmström, Margareta, Eelde, Anna, Bruzelius, Maria, Elgue, Graciela, Wallén, Håkan, Antovic, Aleksandra

Get full text

Increased levels of thrombin-activatable fibrinolysis inhibitor (TAFI) correlate with complement activation in patients with the antiphospholipid syndrome by Antovic, A, Vikerfors, A, Svenungsson, E

Get full text

Thrombin activatable fibrinolysis inhibitor - TAFI as a possible link between coagulation and complement activation in patients with the antiphospholipid syndrome by Antovic, A, Vikerfors, A, Woodhams, B, Adam, M, Svenungsson, E

Get full text

Increased levels of microvesicles containing nuclear molecules and immunoglobulins in patients with systemic lupus erythematosus by Mobarrez, F, Wallen, H, Pisetsky, D, Gunnarsson, I, Gustafsson, J, Zickert, A, Vikerfors, A, Svenungsson, E

Get full text

INCREASED LEVELS OF THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR - TAFI CORRELATE WITH COMPLEMENT ACTIVATION IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME by Antovic, A, Vikerfors, A, Woodhams, B, Adam, M, Svenungsson, E

Get full text

Increased levels of thrombin activatable fibrinolysis inhibitor - TAFI in patients with the antiphospholipid syndrome by Antovic, A, Vikerfors, A, Antovic, JP, Woodhams, B, Adam, M, Svenungsson, E

Get full text

Decreased fibrin clot porosity in patients with antiphospholipid syndrome by Vikerfors, A, Svenungsson, E, Bremme, K, Holmstrom, M, Antovic, A

Get full text

Studies of microparticles in patients with antiphospholipid syndrome (APS) by Vikerfors, A, Mobarrez, F, Bremme, K, Holmstrom, M, Agren, A, Eelde, A, Bruzelius, M, Antovic, A, Wallen, H, Svenungsson, E

Get full text

Severe group A streptococcal infections in Uppsala County, Sweden: Clinical and molecular characterization of a case cluster from 2006 to 2007 by Vikerfors, Anna, Haggar, Axana, Darenberg, Jessica, Low, Aili, Melhus, Åsa, Hedlund, Johan, Sylvan, Staffan, Norrby-Teglund, Anna, Eriksson, Britt-Marie

Get full text

Smoking, Autoantibodies and Vascular Events in Systemic Lupus Erythematosus by Gustafsson, J, Gunnarsson, I, Pettersson, S, Zickert, A, Vikerfors, A, Hellbacher, E, Moller, S, Elvin, K, Kallberg, H, Simard, JF, Svenungsson, E

Get full text

Plasma Levels of Pentraxin 3: A Potential Prognostic Biomarker in Urinary Bladder Cancer Patients by Vikerfors, Anders, Davidsson, Sabina, Carlsson, Jessica, Jerlström, Tomas

Get full text